baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UC DIS.CERT. 09/24 CALL AMD/ DE000HC9CWU7 /

2024-05-21 1:46:07 PM	Chg.0.0000	Bid2024-05-21	Ask-	Underlying	Strike price	Expiration date	Option type
0.8900EUR	0.00%	0.8900 Bid Size: 30,000	- Ask Size: -	ADVANCED MIC.DEV. D...	90.00 -	2024-09-18	Call

GlobeNewswire 3:00 PM AMD Expands EPYC CPU Portfolio to Bring New Levels of Performance and Value for Small and Medium Bus...

GlobeNewswire 1:30 PM Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Protecting the Synapse from ...

GlobeNewswire 1:05 PM Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...

GlobeNewswire 12:55 PM YieldMax™ Launches Option Income Strategy ETF on the VanEck® Gold Miners ETF (GDX®)

TeleTrader 05-20 Microsoft will 'soon welcome' AMD, Intel chips

GlobeNewswire 05-20 Broadcom Revolutionizes AI Networking Landscape with High-Performance 400G RoCE/RDMA Ethernet NICs

Newsfile Corp 05-16 FDA Grants AI-Powered Notal Vision Home OCT "SCANLY" De Novo Marketing Authorization

GlobeNewswire 05-15 Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Cor...

GlobeNewswire 05-14 AMD Announces Upcoming Events for the Financial Community

GlobeNewswire 05-14 Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facilit...

GlobeNewswire 05-14 Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 05-13 Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5...

GlobeNewswire 05-13 AMD Remains the Partner of Choice for World’s Fastest and Most Efficient High Performance Computing ...

GlobeNewswire 05-09 Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 05-09 Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlight...

GlobeNewswire 05-09 4DMT Reports First Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire 05-08 Alkeus Pharmaceuticals Announces Positive Interim Results Demonstrating No Signs of Disease Progress...

GlobeNewswire 05-08 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...

GlobeNewswire 05-08 AMD Receives IEEE 2024 Corporate Innovation Award for Leadership in Chiplet Design for High-Performa...

GlobeNewswire 05-08 Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results

GlobeNewswire 05-08 EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporat...

GlobeNewswire 05-07 Ocular Therapeutix™ Reports First Quarter 2024 Results

GlobeNewswire 05-07 Optiver Chooses AMD Enterprise Portfolio to Power its Data Center Modernization, Enabling New Era of...

GlobeNewswire 05-07 Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results

GlobeNewswire 05-07 Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

UC DIS.CERT. 09/24 CALL AMD/ DE000HC9CWU7 /

If you wish to receive reply to your feedback, please provide your email address.